Literature DB >> 16819538

Gene therapy progress and prospects: cystic fibrosis.

U Griesenbach1, D M Geddes, E W F W Alton.   

Abstract

Our first review on progress and prospects in cystic fibrosis (CF) gene therapy was published in this series in October 2002. We now summarize the progress made since then and comment on the prospects for CF gene therapy over the next couple of years. Three clinical trials have been carried out, further supporting the proof-of-principle that gene transfer to the airway epithelium is feasible. Developments in viral and non-viral vectors, as well as recent alternative strategies such as gene repair, trans-splicing and stem cell therapy will be reviewed.

Entities:  

Mesh:

Year:  2006        PMID: 16819538     DOI: 10.1038/sj.gt.3302809

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  13 in total

1.  Toward gene therapy for cystic fibrosis using a lentivirus pseudotyped with Sendai virus envelopes.

Authors:  Katsuyuki Mitomo; Uta Griesenbach; Makoto Inoue; Lucinda Somerton; Cuixiang Meng; Eiji Akiba; Toshiaki Tabata; Yasuji Ueda; Gad M Frankel; Raymond Farley; Charanjit Singh; Mario Chan; Felix Munkonge; Andrea Brum; Stefania Xenariou; Sara Escudero-Garcia; Mamoru Hasegawa; Eric W F W Alton
Journal:  Mol Ther       Date:  2010-03-23       Impact factor: 11.454

Review 2.  Targeted delivery of nucleic-acid-based therapeutics to the pulmonary circulation.

Authors:  Ramalinga Kuruba; Annette Wilson; Xiang Gao; Song Li
Journal:  AAPS J       Date:  2009-01-09       Impact factor: 4.009

3.  Redesign of extensive protein-DNA interfaces of meganucleases using iterative cycles of in vitro compartmentalization.

Authors:  Ryo Takeuchi; Michael Choi; Barry L Stoddard
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-03       Impact factor: 11.205

Review 4.  Cystic fibrosis transmembrane regulator protein mutations: 'class' opportunity for novel drug innovation.

Authors:  Kelvin D MacDonald; Karen R McKenzie; Pamela L Zeitlin
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

Review 5.  What's new in cystic fibrosis? From treating symptoms to correction of the basic defect.

Authors:  Marijke Proesmans; François Vermeulen; Kris De Boeck
Journal:  Eur J Pediatr       Date:  2008-04-04       Impact factor: 3.183

Review 6.  Barriers to inhaled gene therapy of obstructive lung diseases: A review.

Authors:  Namho Kim; Gregg A Duncan; Justin Hanes; Jung Soo Suk
Journal:  J Control Release       Date:  2016-05-16       Impact factor: 9.776

7.  Lysophosphatidylcholine as an adjuvant for lentiviral vector mediated gene transfer to airway epithelium: effect of acyl chain length.

Authors:  Patricia Cmielewski; Don S Anson; David W Parsons
Journal:  Respir Res       Date:  2010-06-23

8.  Bactofection of lung epithelial cells in vitro and in vivo using a genetically modified Escherichia coli.

Authors:  M D B Larsen; U Griesenbach; S Goussard; D C Gruenert; D M Geddes; R K Scheule; S H Cheng; P Courvalin; C Grillot-Courvalin; E W F W Alton
Journal:  Gene Ther       Date:  2008-01-24       Impact factor: 5.250

9.  Functional cystic fibrosis transmembrane conductance regulator expression in cystic fibrosis airway epithelial cells by AAV6.2-mediated segmental trans-splicing.

Authors:  Yuhu Song; Howard H Lou; Julie L Boyer; Maria P Limberis; Luk H Vandenberghe; Neil R Hackett; Philip L Leopold; James M Wilson; Ronald G Crystal
Journal:  Hum Gene Ther       Date:  2009-03       Impact factor: 5.695

10.  Common gene therapy viral vectors do not efficiently penetrate sputum from cystic fibrosis patients.

Authors:  Kaoru Hida; Samuel K Lai; Jung Soo Suk; Sang Y Won; Michael P Boyle; Justin Hanes
Journal:  PLoS One       Date:  2011-05-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.